Tenpoint Therapeutics
PITCH
A revolution is in sight. Now is our moment to transform the treatment of ocular diseases. Regenerative therapies have unmatched potential to restore sight by replacing lost and dysfunctional tissue in the eye.
LATEST INVESTMENT
#Biotech
07.2023
£57M
UCL Business (UCLB), the UCL Technology Fund & British Patient Capital